Status:
COMPLETED
GLP-1 Infusion and Long-Time Fasting
Lead Sponsor:
University of Aarhus
Conditions:
Type 2 Diabetes
Eligibility:
MALE
20-50 years
Phase:
NA
Brief Summary
GLP-1 is an incretin hormone that simulates insulin secretion and inhibits glucagon secretion in a glucose dependent way. Below normal plasma glucose levels the effects of GLP-1 stop and the risk of h...
Detailed Description
GLP-1 is an incretin hormone that simulates insulin secretion and inhibits glucagon secretion dependent on a normal plasma glucose.It also inhibits gastric emptying and has a trophic effect on the pan...
Eligibility Criteria
Inclusion
- healthy male, age 20-50 years, BMI 20-30 kg/m2, Blood pressure \< 140/90 mmHg, caucasian.
Exclusion
- Diabetes in relatives, anaemia, any significant disease, smoking.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00285896
Start Date
December 1 2005
End Date
May 1 2007
Last Update
July 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of pharmacology, Aarhus university and Medical department M, Aarhus University hospital
Aarhus, Denmark, 8000